Programme Thesis
Generation H 3.0 is a 10-week hybrid HealthTech accelerator run by SET University and the Tokarev Foundation, designed to support early-stage startups with an MVP or scalable product, providing mentorship, regulatory guidance, and market-entry workshops, with a grand prize of 650,000 hryvnias. It exists to foster innovation in the HealthTech sector, initially in Ukraine and now expanding to Ukrainian startups abroad, aiming to create a global hub for healthtech innovation.
Selection Criteria
Eligibility: Open to Ukrainian startups based abroad (for the first time), with an MVP or product ready to scale within 10 weeks. Focus on HealthTech/medical technologies. Evaluation likely based on: product readiness (MVP/scalability), innovation and impact potential, team capability and regulatory understanding, business model viability, and fit with the accelerator's mentorship and market-entry goals. Specific scoring rubric not provided, but emphasis on 'high-quality product' and 'understanding of medical logic, regulatory frameworks, and decision-making cycles' suggests these are key differentiators.
Past Winners / Cohort Profiles
Past cohorts (30 projects over two seasons) include: TAYRA.AI (AI medical scribe), M Shield (drug preventing metastasis), and Ovul (AI fertility tracking device). Alumni have raised 11 million hryvnias, won competitions like Google for Startups, IT Arena, EIT Jumpstarter, entered European and American markets, and made TechCrunch Startup Battlefield top 200. Archetype: early-stage HealthTech startups with a working MVP, strong AI/tech component, and clear regulatory pathway.
Ideal Candidate Fingerprint
The ideal applicant is a Ukrainian-founded HealthTech startup with a validated MVP or product ready to scale, a strong team with both technical and regulatory expertise, and a clear business model for international market entry. They should be able to benefit from intensive mentorship, product testing, and regulatory support, and demonstrate potential for significant impact on healthcare quality of life.
Recommended Framing
For Eniola Olutogun, the strongest angle is to leverage the 'psyche-twin' venture, which is a multi-scale knowledge-graph architecture for self-modeling with a conversational interface, as it aligns with the HealthTech focus on digital health and AI. However, note that the programme is specifically for Ukrainian startups based abroad, so Eniola's Nigerian background may be a significant eligibility issue. If eligible (e.g., via a Ukrainian co-founder or partnership), frame psyche-twin as a scalable digital health product with a clear MVP (the graph and interface) and emphasize regulatory expertise (pharmacist background) and AI/ML capabilities, aligning with the accelerator's emphasis on medical logic and regulatory frameworks.
Watch Out
Eligibility: The programme is explicitly for Ukrainian startups based abroad; Eniola is Nigerian, which may disqualify unless there is a Ukrainian co-founder or the programme's international expansion includes non-Ukrainians (unclear from page). Also, the programme is for startups with an MVP or product ready to scale; Eniola's research lines are mostly academic, not commercial ventures, so only 'psyche-twin' could be positioned as a product, but it may not be at MVP stage. Additionally, the grand prize is in hryvnias (650,000 UAH, ~$17K), which is modest, and the programme may not provide substantial funding for research-focused applicants.
Research History
2026-08-04 20:13 · low confidence
2026-07-31 17:14 · medium confidence